Phase I and pharmacologic study of CT-2584 HMS, a modulator of phosphatidic acid, in adult patients with solid tumours

CT-2584 HMS, 1-(11-dodecylamino-10-hydroxyundecyl)-3,7-dimethylxanthine-hydrogen methanesulphonate, is a modulator of intracellular phosphatidic acid. We treated 30 patients as part of a Phase I and pharmacokinetic study to determine the maximum-tolerated dose of CT-2584 HMS, toxicity profiles, phar...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheeseman, S L, Brannan, M, McGown, A, Khan, P, Gardner, C, Gumbrell, L, Dickens, D, Ranson, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363467/
https://www.ncbi.nlm.nih.gov/pubmed/11104552
http://dx.doi.org/10.1054/bjoc.2000.1503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363467/
https://www.ncbi.nlm.nih.gov/pubmed/11104552
http://dx.doi.org/10.1054/bjoc.2000.1503

Ejemplares similares